August 12, 2025

Wave Life Sciences Ltd. (WVE) Investor Outlook: Analysts See 149% Upside Potential in RNA Therapeutics

Wave Life Sciences Ltd. (NASDAQ: WVE), a Singapore-based biotechnology firm, has been garnering significant attention in the healthcare sector. Specializing in the development of ribonucleic acid..

Mineralys Therapeutics, Inc. (MLYS) Investor Outlook: Exploring a 174% Potential Upside

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is a compelling entry in the biotechnology sector with a specific focus on developing treatments for diseases driven by dysregulated aldosterone...

Schrödinger, Inc. (SDGR) Stock Analysis: Unpacking a Potential 65.8% Upside with Strong Buy Ratings

Schrödinger, Inc. (SDGR) presents a compelling opportunity for growth-oriented investors, with a potential upside of 65.8% according to analyst consensus. Operating within the health information services..

Innoviva, Inc. (INVA) Stock Analysis: Unpacking a Potential 108.65% Upside

Innoviva, Inc. (NASDAQ: INVA), a notable player in the healthcare sector, specifically within the biotechnology industry, presents an intriguing investment case for those looking to capitalize..

Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis: A Closer Look at Growth Potential in the Healthcare Sector

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is carving out a significant niche in the U.S. healthcare sector, focusing on providing comprehensive home care services. With a..

SS Innovations International (SSII) Stock Analysis: A Surgical Robotics Pioneer with Astounding Revenue Growth

SS Innovations International Inc. (SSII), a key player in the healthcare sector, is making significant strides in the medical devices industry with its groundbreaking advancements in..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Pioneer with 47.54% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market cap of $2.11 billion, this Irvine,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a 278.62% Potential Upside in Biotech Breakthrough

For those with an eye on high-risk, high-reward investments, Janux Therapeutics, Inc. (NASDAQ: JANX) presents an intriguing proposition. This San Diego-based biotechnology firm, with a market..

Immunocore Holdings plc (IMCR) Stock Analysis: Exploring a 94.40% Potential Upside in the Biotech Sector

Immunocore Holdings plc (IMCR), a notable player in the biotechnology industry, has captured the attention of investors with a tantalizing potential upside of 94.40%. Headquartered in..

BGM Group Ltd. (BGM): Navigating Uncertainty in the Chinese Healthcare Market

BGM Group Ltd. (BGM), a China-based manufacturer in the healthcare sector, operates within the niche market of specialty and generic drug manufacturing. With a market capitalization..

AtriCure, Inc. (ATRC) Stock Analysis: A Healthcare Play with 40% Potential Upside

AtriCure, Inc. (NASDAQ: ATRC) stands out in the healthcare sector, specifically within the medical instruments and supplies industry, as a company with promising growth potential. With..

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 35.88% Upside Potential Amidst Solid Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a pioneering biopharmaceutical firm specializing in cellular metabolism therapies, offers an intriguing investment opportunity in the volatile biotechnology sector. With its..

Evolent Health, Inc (EVH) Stock Analysis: Exploring a 66% Potential Upside Amidst Mixed Financials

Evolent Health, Inc (NASDAQ: EVH) presents an intriguing proposition for investors, especially those captivated by the potential high-reward scenarios. As a prominent player in the healthcare..

Galapagos NV (GLPG) Stock Analysis: Navigating Challenges in the Biotech Sector with a 19% Downside Potential

Galapagos NV (NASDAQ: GLPG), the Belgium-based biotechnology company, stands at a critical juncture, poised between innovative potential and financial headwinds. As the company continues to forge..

Integra LifeSciences Holdings (IART) Stock Analysis: Navigating a 24.51% Potential Upside Amidst Industry Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the healthcare sector, particularly in the medical devices industry, presents a complex yet intriguing picture for..

BioLife Solutions, Inc. (BLFS) Investor Outlook: Analysts Project Nearly 40% Upside Potential

BioLife Solutions, Inc. (BLFS), a key player in the healthcare sector, is capturing the attention of investors with its robust position in the medical instruments and..

Apellis Pharmaceuticals (APLS) Stock Analysis: Navigating a 58% Potential Upside in the Biotech Sector

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is a compelling name for investors eyeing opportunities in the healthcare sector’s biotechnology industry. With a market capitalization of $3.01 billion,..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Unpacking the 74% Potential Upside

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) has captured the attention of the investor community with its remarkable potential upside of 74.22%, according to analyst ratings. As a..

Astrana Health Inc. (ASTH) Stock Analysis: Tapping Into a 52.98% Potential Upside

Astrana Health Inc. (ASTH), a burgeoning name in the healthcare sector, is capturing investor attention with its promising revenue growth and substantial potential upside. The company’s..

Indivior PLC (INDV) Stock Analysis: Unlocking a 22.63% Potential Upside in the Healthcare Sector

Indivior PLC (INDV) stands out in the healthcare sector as a promising investment, primarily due to its focus on developing and manufacturing prescription drugs aimed at..

Search

Funds

August 12, 2025

Search

Funds

August 12, 2025

FTSE 100

Funds